Philip Empey
PE
Philip Empey is the Associate Director for Pharmacogenomics of the Pitt/UPMC Institute for Precision Medicine and leads the PreCISE-Rx and Test2Learn teams to implement pharmacogenomics clinical, research, and educational initiatives. He also directs the Pharamcogenomics Center of Excellence which is deploying population scale preemptive pharmagenomics testing (to >150,000 patients) in Western Pennsylvania. As a clinician-scientist in the Department of Pharmacy and Therapeutics, he conducts NIH-funded clinical and translational research aimed at understanding the mechanisms of the variability in drug response to improve medication-related outcomes in critically-ill patients.
You Likely Have Genes That Affect How Well Your Medications Work— Testing for Them Could Improve Treatment
Pharmacogenomics studies how genetics interacts with drug
November 22, 2026


